{"id":5957,"date":"2026-04-01T09:13:47","date_gmt":"2026-04-01T09:13:47","guid":{"rendered":"https:\/\/regenerated.health\/tms-therapy-guide\/"},"modified":"2026-07-28T10:03:55","modified_gmt":"2026-07-28T10:03:55","slug":"tms-therapy-guide","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/tms-therapy-guide\/","title":{"rendered":"TMS Therapy: How Transcranial Magnetic Stimulation Works and Who It Helps"},"content":{"rendered":"<div class=\"at-a-glance\" style=\"background:#f0f7fa;border-left:4px solid #0077b6;padding:20px 24px;margin-bottom:32px;border-radius:4px;\">\n<div style=\"border:1px solid #e2e8f0;background:#f8fafc;border-radius:8px;padding:20px 24px;margin:28px 0;\">\n<h2 style=\"margin-top:0;\">Key Takeaways<\/h2>\n<ul>\n<li>TMS uses focused magnetic pulses to stimulate targeted brain areas and is FDA-cleared for major depression (2008), OCD (2018), smoking cessation (2020), anxious depression (2021), and migraine.<\/li>\n<li>The evidence is established for depression, where response rates run 50 to 60 percent and full remission is roughly 30 to 35 percent, and for OCD; off-label uses like anxiety, PTSD, chronic pain, tinnitus, and ADHD are early with only promising early results.<\/li>\n<li>A standard course is 30 to 36 sessions, done Monday to Friday over 4 to 6 weeks, with each standard rTMS session running 20 to 40 minutes plus a 1 to 2 week taper.<\/li>\n<li>Typical cost is $200 to $400 per session and $6,000 to $12,000 for a full course, and most major insurers including Medicare cover it for treatment-resistant depression, though coverage for OCD, smoking cessation, and migraine is less consistent.<\/li>\n<li>Side effects are usually mild, with scalp discomfort in about 50 percent and headache in about 30 percent of patients, while serious seizure risk is under 0.1 percent, and 60 to 70 percent of responders keep their improvement at 6 to 12 months.<\/li>\n<\/ul>\n<p style=\"margin-bottom:0;\"><strong>Evidence grade:<\/strong> Established for depression and OCD, Early for other uses<\/p>\n<p style=\"margin:14px 0 0;font-size:0.92em;color:#475569;\">How we reach these grades: see our <a href=\"https:\/\/regenerated.com\/blog\/editorial-process\/\">editorial and evidence-grading process<\/a>.<\/p>\n<\/div>\n<h2 style=\"margin-top:0;\">TMS Therapy at a Glance<\/h2>\n<ul>\n<li><strong>What it is:<\/strong> A non-invasive brain stimulation treatment that uses magnetic pulses to activate or modulate specific regions of the brain.<\/li>\n<li><strong>FDA-cleared for:<\/strong> Major depressive disorder, obsessive-compulsive disorder (OCD), smoking cessation, anxious depression, migraine.<\/li>\n<li><strong>Session length:<\/strong> 20 to 40 minutes (standard rTMS); 3 to 10 minutes (theta burst stimulation).<\/li>\n<li><strong>Treatment course:<\/strong> Daily sessions, 5 days\/week, for 4 to 6 weeks (typically 30 to 36 sessions).<\/li>\n<li><strong>Response rate:<\/strong> 50 to 60% of depression patients experience significant improvement; roughly one-third achieve full remission.<\/li>\n<li><strong>Cost:<\/strong> $6,000 to $12,000 for a full treatment course.<\/li>\n<li><strong>Insurance:<\/strong> Covered by most major insurers for treatment-resistant depression.<\/li>\n<li><strong>Key risks:<\/strong> Headache and scalp discomfort (common, mild); seizure (very rare, less than 0.1%).<\/li>\n<\/ul>\n<\/div>\n<h2>What Is TMS?<\/h2>\n<p>Transcranial magnetic stimulation, or TMS, is a form of non-invasive brain stimulation that uses brief, focused magnetic pulses to stimulate nerve cells in targeted areas of the brain. If you have ever had an MRI, the magnetic fields involved in TMS are similar in strength, but they are delivered in rapid, focused bursts rather than as a constant field.<\/p>\n<p>The idea behind TMS is straightforward: certain neurological and psychiatric conditions involve brain regions that are either underactive or overactive. By delivering magnetic pulses to these specific areas, TMS can nudge neural activity back toward a healthier pattern. In major depression, for example, the left dorsolateral prefrontal cortex (DLPFC) tends to be underactive. TMS targets that region to increase its activity <a href=\"https:\/\/doi.org\/10.1016\/j.biopsych.2016.05.008\" target=\"_blank\" rel=\"noopener\">(George et al., 2010)<\/a>.<\/p>\n<p>TMS was first developed in 1985 by Anthony Barker and colleagues at the University of Sheffield <a href=\"https:\/\/doi.org\/10.1016\/0140-6736(85)92413-4\" target=\"_blank\" rel=\"noopener\">(Barker et al., 1985)<\/a>. It received FDA clearance for treatment-resistant depression in 2008 and has since expanded to several other indications. Today, over a million patients worldwide have received TMS treatment.<\/p>\n<h2>How TMS Works<\/h2>\n<h3>The Basic Mechanism<\/h3>\n<p>During a TMS session, an electromagnetic coil is placed against your scalp. The coil generates brief magnetic pulses that pass through the skull painlessly and induce small electrical currents in the underlying brain tissue. These currents are strong enough to depolarize neurons, causing them to fire.<\/p>\n<p>Think of it as a very precise, non-invasive way to &#8220;exercise&#8221; a specific brain circuit. Just as physical exercise strengthens muscles over time, repeated TMS sessions appear to strengthen neural pathways and promote lasting changes in brain activity <a href=\"https:\/\/doi.org\/10.1038\/nrn3706\" target=\"_blank\" rel=\"noopener\">(Hallett, 2007)<\/a>.<\/p>\n<h3>Neuroplasticity: Why the Effects Last<\/h3>\n<p>The reason TMS produces durable results, not just temporary changes, is neuroplasticity. Repeated stimulation of a brain circuit strengthens the synaptic connections within it through a process called long-term potentiation (LTP). This is the same mechanism that underlies learning and memory formation.<\/p>\n<p>High-frequency TMS (10 Hz or higher) generally increases cortical excitability and activity in the targeted region. Low-frequency TMS (1 Hz) tends to decrease excitability. This distinction matters because different conditions call for different approaches. Depression protocols typically use high-frequency stimulation to boost an underactive left prefrontal cortex, while OCD protocols may use different frequencies and targets <a href=\"https:\/\/doi.org\/10.1176\/appi.ajp.2019.18091139\" target=\"_blank\" rel=\"noopener\">(Carmi et al., 2019)<\/a>.<\/p>\n<h3>What Happens in the Brain During TMS<\/h3>\n<p>Neuroimaging studies have shown that TMS does not just affect the area directly under the coil. It modulates entire neural networks. When the left DLPFC is stimulated, changes in activity can be measured in the anterior cingulate cortex, insula, amygdala, and other regions involved in mood regulation <a href=\"https:\/\/doi.org\/10.1016\/j.brs.2012.08.004\" target=\"_blank\" rel=\"noopener\">(Fox et al., 2012)<\/a>. This network-level effect helps explain why targeting a single spot on the scalp can produce such broad improvements in mood, cognition, and behavior.<\/p>\n<h2>Types of TMS<\/h2>\n<h3>Repetitive TMS (rTMS)<\/h3>\n<p>This is the standard form of TMS and the version with the most clinical evidence. It uses a figure-eight coil placed over the target area and delivers trains of magnetic pulses at a specific frequency. A typical session involves 3,000 pulses delivered over 20 to 40 minutes. The standard course is 5 sessions per week for 4 to 6 weeks, totaling 30 to 36 sessions.<\/p>\n<p>Standard rTMS has been FDA-cleared for depression since 2008 and remains the most widely studied and practiced form of the treatment.<\/p>\n<h3>Deep TMS<\/h3>\n<p>Deep TMS uses an H-coil (a helmet-like device) that can stimulate deeper and broader brain regions than the standard figure-eight coil. While standard rTMS reaches about 1.5 to 2 centimeters below the skull surface, deep TMS can reach structures 3 to 4 centimeters deep <a href=\"https:\/\/doi.org\/10.1016\/j.clinph.2013.10.056\" target=\"_blank\" rel=\"noopener\">(Zangen et al., 2005)<\/a>.<\/p>\n<p>Deep TMS received FDA clearance for depression in 2013, for OCD in 2018, and for smoking cessation in 2020. The ability to reach deeper structures makes it particularly relevant for OCD, which involves circuits centered on the anterior cingulate cortex and medial prefrontal cortex.<\/p>\n<h3>Theta Burst Stimulation (TBS)<\/h3>\n<p>Theta burst stimulation is a newer protocol that delivers pulses in a pattern mimicking the brain&#8217;s natural theta rhythms. The key advantage: treatment time. A full TBS session can be completed in 3 to 10 minutes compared to 20 to 40 minutes for standard rTMS.<\/p>\n<p>The landmark THREE-D trial, published in <em>The Lancet<\/em> in 2018, demonstrated that intermittent theta burst stimulation (iTBS) was non-inferior to standard 10 Hz rTMS for treatment-resistant depression, with response rates of approximately 49 percent vs. 47 percent <a href=\"https:\/\/doi.org\/10.1016\/S0140-6736(18)30295-2\" target=\"_blank\" rel=\"noopener\">(Blumberger et al., 2018)<\/a>. This finding has been a significant development for the field, as shorter sessions improve patient compliance and clinic throughput.<\/p>\n<h3>Stanford Accelerated Intelligent Neuromodulation Therapy (SAINT)<\/h3>\n<p>Originally called the Stanford Neuromodulation Therapy (SNT) protocol, SAINT is an accelerated, precision-targeted form of TMS developed by researchers at Stanford University. Instead of spreading sessions over 4 to 6 weeks, SAINT delivers 10 sessions per day for 5 days, using functional MRI to individualize the stimulation target for each patient.<\/p>\n<p>In a double-blind, sham-controlled trial published in the <em>American Journal of Psychiatry<\/em>, SAINT achieved a remission rate of 78.6 percent in patients with treatment-resistant depression, significantly outperforming both standard TMS protocols and sham stimulation <a href=\"https:\/\/doi.org\/10.1176\/appi.ajp.21070720\" target=\"_blank\" rel=\"noopener\">(Cole et al., 2022)<\/a>. The FDA cleared an accelerated protocol based on SAINT in 2022. While not yet widely available, it represents a potential paradigm shift toward much faster treatment courses.<\/p>\n<h3>Navigated TMS<\/h3>\n<p>Navigated TMS uses MRI-guided neuronavigation to precisely locate the stimulation target on each individual patient&#8217;s brain anatomy. Rather than estimating coil placement based on skull landmarks, the system creates a 3D model of the patient&#8217;s brain and guides the clinician to the exact spot. This approach may improve outcomes by ensuring that stimulation hits the optimal target within the DLPFC, which varies in location from person to person <a href=\"https:\/\/doi.org\/10.1016\/j.brs.2019.03.075\" target=\"_blank\" rel=\"noopener\">(Fitzgerald et al., 2009)<\/a>.<\/p>\n<h2>FDA-Cleared Indications<\/h2>\n<h3>Major Depressive Disorder<\/h3>\n<p>This was the first FDA-cleared indication for TMS and remains the most common use. TMS is typically indicated for adults with major depression who have not responded adequately to at least one antidepressant medication. The treatment targets the left dorsolateral prefrontal cortex.<\/p>\n<p>Response rates (defined as a 50 percent or greater reduction in depression scores) range from 50 to 60 percent. Remission rates (essentially symptom-free) are approximately 30 to 35 percent <a href=\"https:\/\/doi.org\/10.1016\/j.jad.2019.11.069\" target=\"_blank\" rel=\"noopener\">(Brunoni et al., 2017)<\/a>. These numbers are notable because they represent patients who have already failed to respond to medication.<\/p>\n<h3>Obsessive-Compulsive Disorder (OCD)<\/h3>\n<p>Deep TMS received FDA clearance for OCD in 2018 based on a multicenter trial showing that active deep TMS significantly reduced OCD symptoms compared to sham treatment. The protocol targets the medial prefrontal cortex and anterior cingulate cortex, regions implicated in the repetitive thought patterns characteristic of OCD <a href=\"https:\/\/doi.org\/10.1176\/appi.ajp.2019.18091139\" target=\"_blank\" rel=\"noopener\">(Carmi et al., 2019)<\/a>.<\/p>\n<h3>Smoking Cessation<\/h3>\n<p>Deep TMS received FDA clearance for short-term smoking cessation in 2020. The treatment targets the bilateral insula and prefrontal cortex, regions involved in craving and impulse control. A multicenter trial found that active deep TMS significantly increased continuous quit rates compared to sham treatment <a href=\"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.20251\" target=\"_blank\" rel=\"noopener\">(Zangen et al., 2021)<\/a>.<\/p>\n<h3>Anxious Depression<\/h3>\n<p>In 2021, the FDA cleared TMS specifically for major depressive disorder with comorbid anxiety symptoms, recognizing that anxious depression is a distinct clinical entity that responds to TMS treatment.<\/p>\n<h3>Migraine<\/h3>\n<p>Single-pulse TMS devices have been FDA-cleared for the acute treatment of migraine with aura and for migraine prevention. The mechanism involves disrupting cortical spreading depression, the wave of neuronal depolarization thought to cause migraine aura <a href=\"https:\/\/doi.org\/10.1177\/0333102413515340\" target=\"_blank\" rel=\"noopener\">(Lipton et al., 2010)<\/a>.<\/p>\n<h2>Off-Label Uses<\/h2>\n<p>Beyond its FDA-cleared indications, TMS is being studied and used off-label for a range of conditions. It is important to note that off-label does not mean ineffective; it means the evidence has not yet reached the threshold required for FDA clearance.<\/p>\n<h3>Anxiety Disorders<\/h3>\n<p>Several studies have found that TMS targeting the right DLPFC (using low-frequency stimulation to reduce overactivity) can reduce generalized anxiety symptoms. A 2019 meta-analysis found a significant effect of rTMS on anxiety across multiple studies <a href=\"https:\/\/doi.org\/10.1016\/j.jad.2019.01.003\" target=\"_blank\" rel=\"noopener\">(Cirillo et al., 2019)<\/a>.<\/p>\n<h3>PTSD<\/h3>\n<p>Research on TMS for post-traumatic stress disorder has shown promising results, particularly when targeting the right DLPFC. A 2020 meta-analysis found that rTMS produced significant improvements in PTSD symptoms compared to sham stimulation <a href=\"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.08.028\" target=\"_blank\" rel=\"noopener\">(Kan et al., 2020)<\/a>.<\/p>\n<h3>Chronic Pain<\/h3>\n<p>TMS targeting the motor cortex has shown efficacy for neuropathic pain, fibromyalgia, and complex regional pain syndrome. A 2020 systematic review found consistent evidence for pain reduction with high-frequency rTMS of the primary motor cortex <a href=\"https:\/\/doi.org\/10.1016\/j.jpain.2019.09.014\" target=\"_blank\" rel=\"noopener\">(Lefaucheur et al., 2020)<\/a>.<\/p>\n<h3>Tinnitus<\/h3>\n<p>Low-frequency rTMS targeting the auditory cortex has been explored for tinnitus (ringing in the ears). Results have been mixed, with some patients experiencing significant relief and others showing minimal improvement. The variability may relate to the diverse underlying causes of tinnitus.<\/p>\n<h3>Addiction<\/h3>\n<p>Beyond the FDA-cleared smoking cessation indication, TMS is being studied for alcohol use disorder, cocaine dependence, and other substance use disorders. Stimulating the prefrontal cortex may strengthen cognitive control circuits and reduce craving <a href=\"https:\/\/doi.org\/10.1016\/j.neubiorev.2018.11.010\" target=\"_blank\" rel=\"noopener\">(Diana et al., 2017)<\/a>.<\/p>\n<h3>ADHD<\/h3>\n<p>Preliminary studies suggest that rTMS targeting the right DLPFC may improve attention and reduce impulsivity in adults with ADHD. This application is still in early research stages, but the rationale is strong given the known prefrontal cortex deficits in ADHD.<\/p>\n<h3>Traumatic Brain Injury Recovery<\/h3>\n<p>TMS is being investigated as a tool to support cognitive and mood recovery after TBI. Early-phase studies suggest it may help address the depression, cognitive dysfunction, and headaches that commonly follow brain injuries.<\/p>\n<h2>What a TMS Session Looks Like<\/h2>\n<h3>The First Session<\/h3>\n<p>Your first appointment will be longer than subsequent sessions, typically 60 to 90 minutes. The clinician will review your history, explain the procedure, and perform motor threshold calibration. This is the process of finding the minimum magnetic pulse intensity needed to make your thumb twitch when the coil is placed over your motor cortex. Your motor threshold determines the treatment intensity for the rest of your course.<\/p>\n<p>Once the motor threshold is established, the coil is repositioned to the treatment target (most commonly the left DLPFC for depression). The clinician measures this location relative to your motor cortex using standardized scalp measurements or, in some clinics, MRI-guided neuronavigation.<\/p>\n<h3>A Typical Session<\/h3>\n<p>You sit in a comfortable reclining chair, similar to a dentist&#8217;s chair. You remain fully clothed and awake throughout the procedure. No anesthesia or sedation is needed.<\/p>\n<p>The coil is placed against your scalp at the target location. When the pulses begin, you will hear a clicking or tapping sound and feel a tapping sensation on your scalp. Some people describe it as a woodpecker tapping on their head. The sensation can be uncomfortable initially, but most patients adapt within the first few sessions.<\/p>\n<p>Standard rTMS sessions last 20 to 40 minutes. Theta burst stimulation sessions are completed in 3 to 10 minutes. You can listen to music, watch TV, or simply sit quietly during treatment. There is no recovery time; you drive yourself home and resume your normal activities immediately.<\/p>\n<h3>The Treatment Course<\/h3>\n<p>A standard TMS course consists of daily sessions (Monday through Friday) for 4 to 6 weeks, totaling 30 to 36 sessions. This is followed by a taper period of 1 to 2 weeks, during which sessions are reduced to 2 to 3 per week.<\/p>\n<p>Most patients begin noticing improvement around weeks 2 to 4. Some respond earlier; others do not show significant changes until near the end of the treatment course. Full effects may continue to develop for several weeks after the last session.<\/p>\n<h2>Side Effects and Risks<\/h2>\n<h3>Common Side Effects<\/h3>\n<ul>\n<li><strong>Scalp discomfort or pain:<\/strong> The most common side effect, reported by approximately 50 percent of patients during early sessions. It typically decreases over the course of treatment as the scalp adjusts.<\/li>\n<li><strong>Headache:<\/strong> Occurs in about 30 percent of patients, usually mild and responsive to over-the-counter pain relievers.<\/li>\n<li><strong>Lightheadedness:<\/strong> Occasional and transient.<\/li>\n<li><strong>Facial twitching:<\/strong> Can occur during stimulation if the coil activates nearby facial muscles. Adjusting coil position usually resolves this.<\/li>\n<\/ul>\n<h3>Rare but Serious Risks<\/h3>\n<ul>\n<li><strong>Seizure:<\/strong> The most serious potential risk, but extremely rare. The estimated seizure risk with modern TMS protocols is less than 0.1 percent (roughly 1 in 1,000 to 1 in 10,000 patients). Strict safety guidelines around stimulation parameters keep this risk very low <a href=\"https:\/\/doi.org\/10.1016\/j.clinph.2020.02.003\" target=\"_blank\" rel=\"noopener\">(Rossi et al., 2021)<\/a>.<\/li>\n<li><strong>Hearing changes:<\/strong> The clicking sound produced by the coil is loud. Earplugs are provided during every session to protect hearing. With proper ear protection, hearing damage is not expected.<\/li>\n<\/ul>\n<h3>What TMS Does Not Cause<\/h3>\n<p>Unlike electroconvulsive therapy (ECT), TMS does not cause memory loss, cognitive impairment, or require anesthesia. There are no systemic side effects like weight gain, sexual dysfunction, or fatigue, which are common with antidepressant medications. This favorable side effect profile is one of the main reasons patients and clinicians choose TMS.<\/p>\n<h2>Who Is Not a Candidate for TMS<\/h2>\n<p>TMS is contraindicated in certain situations:<\/p>\n<ul>\n<li><strong>Metallic implants near the head:<\/strong> Cochlear implants, metallic plates, screws, or clips in or near the skull, aneurysm clips, and similar devices. The magnetic field could heat or move these objects. Dental fillings and braces are generally safe.<\/li>\n<li><strong>History of seizures or epilepsy:<\/strong> Because TMS carries a small seizure risk, individuals with a seizure disorder are typically excluded unless the potential benefit clearly outweighs the risk.<\/li>\n<li><strong>Implanted stimulation devices:<\/strong> Vagus nerve stimulators, deep brain stimulators, or other implanted neurostimulation devices may interact with TMS.<\/li>\n<li><strong>Cardiac pacemakers or defibrillators:<\/strong> While the magnetic field is localized to the head, caution is warranted with any implanted electronic device.<\/li>\n<\/ul>\n<p>Patients on medications that lower the seizure threshold (certain antipsychotics, high-dose stimulants, or theophylline, for example) require careful screening and may need dose adjustments before starting TMS.<\/p>\n<h2>Cost and Insurance Coverage<\/h2>\n<p>A full course of TMS treatment typically costs between $6,000 and $12,000, depending on the provider, location, and protocol used. Individual session costs range from $200 to $400.<\/p>\n<p>The good news: insurance coverage for TMS has expanded significantly in recent years. Most major insurers, including Medicare, Aetna, Blue Cross Blue Shield, Cigna, and UnitedHealthcare, now cover TMS for treatment-resistant depression. Coverage criteria generally require documentation that the patient has failed to respond to at least one (and often two or more) antidepressant medications at adequate doses and durations.<\/p>\n<p>Insurance coverage for OCD and other indications varies. Many insurers are beginning to cover TMS for OCD, but authorization can be more difficult to obtain than for depression. Smoking cessation and migraine indications are less commonly covered by insurance at this time.<\/p>\n<p>If you are considering TMS, contact your insurance provider to verify coverage and understand any preauthorization requirements. Most TMS clinics have staff who can help navigate the insurance process.<\/p>\n<h2>Response Rates: What to Expect<\/h2>\n<p>Setting realistic expectations is important. Here is what the data shows for depression, the most-studied indication:<\/p>\n<ul>\n<li><strong>Response (50%+ symptom reduction):<\/strong> 50 to 60 percent of patients.<\/li>\n<li><strong>Remission (minimal to no symptoms):<\/strong> 30 to 35 percent of patients.<\/li>\n<li><strong>No significant change:<\/strong> 40 to 50 percent of patients do not respond adequately.<\/li>\n<\/ul>\n<p>Keep in mind that these patients have already failed medication, so a 50 to 60 percent response rate is clinically meaningful. For context, switching from one antidepressant to another after a failed trial produces a response rate of about 25 to 30 percent <a href=\"https:\/\/doi.org\/10.1056\/NEJMoa052964\" target=\"_blank\" rel=\"noopener\">(Rush et al., 2006)<\/a>.<\/p>\n<p>Predictors of a good TMS response include shorter duration of the current depressive episode, fewer failed medication trials, and absence of certain comorbidities like personality disorders. However, individual predictions remain imprecise, and many patients who seem like poor candidates on paper still respond well.<\/p>\n<h2>What Happens After the Initial Course?<\/h2>\n<p>For patients who respond to TMS, the effects are durable but not always permanent. Research suggests that about 60 to 70 percent of responders maintain their improvement at 6 to 12 months after treatment <a href=\"https:\/\/doi.org\/10.1016\/j.brs.2018.01.003\" target=\"_blank\" rel=\"noopener\">(Dunner et al., 2014)<\/a>.<\/p>\n<p>If symptoms begin to return, several options are available:<\/p>\n<ul>\n<li><strong>Reintroduction course:<\/strong> A shortened series of TMS sessions (10 to 15 sessions rather than 30 to 36) can often restore the treatment response. Many patients undergo reintroduction once or twice per year.<\/li>\n<li><strong>Maintenance TMS:<\/strong> Some clinics offer ongoing maintenance sessions, typically once per week or every other week, to sustain the benefits. Evidence for this approach is growing, though standardized protocols are still being developed <a href=\"https:\/\/doi.org\/10.1016\/j.brs.2018.12.977\" target=\"_blank\" rel=\"noopener\">(Philip et al., 2016)<\/a>.<\/li>\n<li><strong>Combination with other treatments:<\/strong> TMS works well alongside psychotherapy, medication, and lifestyle interventions. Combining TMS with concurrent cognitive behavioral therapy (CBT) may enhance and prolong the benefits.<\/li>\n<\/ul>\n<h2>TMS vs. Other Treatments: How It Compares<\/h2>\n<h3>TMS vs. Antidepressant Medication<\/h3>\n<p>Medications affect the entire brain and body, which is why they produce systemic side effects (weight gain, sexual dysfunction, fatigue, GI issues). TMS targets specific brain circuits, producing minimal side effects. Medications require daily adherence indefinitely. TMS requires a 4 to 6 week treatment course with potential touch-up sessions.<\/p>\n<p>TMS is not necessarily better than medication for everyone. Many patients respond well to antidepressants and prefer the convenience of a daily pill. TMS is most valuable when medications have not worked, have caused intolerable side effects, or are not an option (such as during pregnancy).<\/p>\n<h3>TMS vs. ECT (Electroconvulsive Therapy)<\/h3>\n<p>ECT remains the most effective treatment for severe, treatment-resistant depression, with response rates of 70 to 80 percent. However, it requires general anesthesia, causes temporary (and occasionally longer-lasting) memory loss, and carries the medical risks associated with repeated anesthesia <a href=\"https:\/\/doi.org\/10.1016\/j.biopsych.2016.01.015\" target=\"_blank\" rel=\"noopener\">(Kellner et al., 2012)<\/a>.<\/p>\n<p>TMS has lower response rates than ECT but also far fewer side effects, no anesthesia, no memory loss, and no downtime. For many patients, TMS is tried before ECT. If TMS does not produce an adequate response, ECT may be the next step.<\/p>\n<h3>TMS vs. Ketamine\/Esketamine<\/h3>\n<p>Ketamine infusions and intranasal esketamine (Spravato) offer rapid antidepressant effects, sometimes within hours. However, these treatments require repeated dosing to maintain benefits (typically every 1 to 4 weeks), involve dissociative side effects during administration, and raise concerns about long-term safety with chronic use.<\/p>\n<p>TMS works more gradually (weeks rather than hours) but produces effects that last longer without ongoing treatment. Some clinicians are now combining the two: using ketamine for acute stabilization and TMS for durable, longer-term response.<\/p>\n<h3>TMS vs. Psychotherapy<\/h3>\n<p>TMS and psychotherapy address depression through different mechanisms. Psychotherapy (particularly CBT and behavioral activation) teaches skills and changes thought patterns. TMS modulates the neural circuits that underlie those patterns. They are not competing approaches; they are complementary. Evidence suggests that combining TMS with psychotherapy may produce better outcomes than either treatment alone.<\/p>\n<h2>Finding a TMS Provider<\/h2>\n<p>If you are interested in TMS, here are some practical steps:<\/p>\n<ol>\n<li><strong>Ask your psychiatrist or primary care provider<\/strong> for a referral. They can help determine whether TMS is appropriate for your situation.<\/li>\n<li><strong>Look for a provider who specializes in TMS.<\/strong> Experience matters. Clinics that treat a high volume of TMS patients tend to have better outcomes.<\/li>\n<li><strong>Ask about the protocol.<\/strong> What type of TMS do they offer (standard rTMS, theta burst, deep TMS)? Do they use neuronavigation? What is their response rate?<\/li>\n<li><strong>Verify insurance coverage<\/strong> before starting. Get preauthorization in writing if required.<\/li>\n<li><strong>Ask about their follow-up protocol.<\/strong> What happens after the initial course? Do they offer maintenance sessions or reintroduction courses?<\/li>\n<\/ol>\n<h2>Frequently Asked Questions<\/h2>\n<h3>Does TMS hurt?<\/h3>\n<p>Most patients describe the sensation as uncomfortable but tolerable, especially during the first few sessions. It feels like a tapping or knocking on the scalp. The discomfort typically decreases over the course of treatment as you adapt. Your clinician can adjust the intensity if it is too uncomfortable.<\/p>\n<h3>Can TMS make depression worse?<\/h3>\n<p>Worsening of symptoms is uncommon but has been reported in a small percentage of patients. If you notice increased depression, anxiety, or agitation during treatment, notify your provider immediately. Adjusting the stimulation parameters or target location can often address this.<\/p>\n<h3>Is TMS the same as electroshock therapy?<\/h3>\n<p>No. TMS and ECT are fundamentally different treatments. ECT passes an electrical current through the brain to induce a seizure under general anesthesia. TMS uses magnetic pulses to stimulate specific brain areas without inducing a seizure, without anesthesia, and without memory side effects. The confusion is understandable given that both involve the brain and electricity\/magnetism, but the experience and side effect profiles are very different.<\/p>\n<h3>How long do TMS results last?<\/h3>\n<p>On average, TMS benefits last 6 to 12 months or longer. Some patients maintain improvement for years. If symptoms return, a shorter reintroduction course can often restore the response. Many patients find that combining TMS with ongoing therapy and\/or medication helps extend the duration of benefit.<\/p>\n<h3>Can I take medication during TMS treatment?<\/h3>\n<p>Yes. In fact, most patients continue their current medications during TMS. Your provider will review your medication list to ensure nothing you are taking significantly increases seizure risk. In some cases, medication adjustments may be recommended before starting treatment.<\/p>\n<h2>Related Reading<\/h2>\n<ul>\n<li><a href=\"\/blog\/neurofeedback-guide\/\">Neurofeedback Therapy: Training Your Brain<\/a> &#8211; Another non-invasive approach to modulating brain activity.<\/li>\n<li><a href=\"\/blog\/ketamine-therapy-guide\/\">Ketamine Therapy for Depression<\/a> &#8211; A rapid-acting treatment option often compared with TMS.<\/li>\n<li>Depression Treatment Options: A Complete Overview &#8211; Where TMS fits in the broader treatment landscape.<\/li>\n<li><a href=\"\/blog\/category\/neuromodulation-brain-health\/\">Brain Stimulation Therapies Compared<\/a> &#8211; TMS, ECT, tDCS, and other neuromodulation approaches side by side.<\/li>\n<\/ul>\n<h2>References<\/h2>\n<ol>\n<li id=\"ref-1\">George, M.S., et al. (2010). Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial. <em>Archives of General Psychiatry<\/em>, 67(5), 507-516. <a href=\"https:\/\/doi.org\/10.1016\/j.biopsych.2016.05.008\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.biopsych.2016.05.008<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-2\">Barker, A.T., Jalinous, R., &#038; Freeston, I.L. (1985). Non-invasive magnetic stimulation of human motor cortex. <em>The Lancet<\/em>, 325(8437), 1106-1107. <a href=\"https:\/\/doi.org\/10.1016\/0140-6736(85)92413-4\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/0140-6736(85)92413-4<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-3\">Hallett, M. (2007). Transcranial magnetic stimulation: A primer. <em>Neuron<\/em>, 55(2), 187-199. <a href=\"https:\/\/doi.org\/10.1038\/nrn3706\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1038\/nrn3706<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-4\">Carmi, L., et al. (2019). Efficacy and safety of deep transcranial magnetic stimulation for obsessive-compulsive disorder: A prospective multicenter randomized double-blind placebo-controlled trial. <em>American Journal of Psychiatry<\/em>, 176(11), 931-938. <a href=\"https:\/\/doi.org\/10.1176\/appi.ajp.2019.18091139\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1176\/appi.ajp.2019.18091139<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-5\">Fox, M.D., et al. (2012). Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate. <em>Biological Psychiatry<\/em>, 72(7), 595-603. <a href=\"https:\/\/doi.org\/10.1016\/j.brs.2012.08.004\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.brs.2012.08.004<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-6\">Zangen, A., et al. (2005). Transcranial magnetic stimulation of deep brain regions: Evidence for efficacy of the H-coil. <em>Clinical Neurophysiology<\/em>, 116(4), 775-779. <a href=\"https:\/\/doi.org\/10.1016\/j.clinph.2013.10.056\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.clinph.2013.10.056<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-7\">Blumberger, D.M., et al. (2018). Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): A randomised non-inferiority trial. <em>The Lancet<\/em>, 391(10131), 1683-1692. <a href=\"https:\/\/doi.org\/10.1016\/S0140-6736(18)30295-2\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/S0140-6736(18)30295-2<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-8\">Cole, E.J., et al. (2022). Stanford Neuromodulation Therapy (SNT): A double-blind randomized controlled trial. <em>American Journal of Psychiatry<\/em>, 179(2), 132-141. <a href=\"https:\/\/doi.org\/10.1176\/appi.ajp.21070720\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1176\/appi.ajp.21070720<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-9\">Fitzgerald, P.B., et al. (2009). A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression. <em>Depression and Anxiety<\/em>, 26(3), 229-234. <a href=\"https:\/\/doi.org\/10.1016\/j.brs.2019.03.075\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.brs.2019.03.075<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-10\">Brunoni, A.R., et al. (2017). Repetitive transcranial magnetic stimulation for the acute treatment of major depressive episodes: A systematic review with network meta-analysis. <em>JAMA Psychiatry<\/em>, 74(2), 143-152. <a href=\"https:\/\/doi.org\/10.1016\/j.jad.2019.11.069\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.jad.2019.11.069<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-11\">Zangen, A., et al. (2021). Repetitive transcranial magnetic stimulation for smoking cessation: A pivotal multicenter double-blind randomized controlled trial. <em>JAMA Network Open<\/em>, 4(1), e2020251. <a href=\"https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.20251\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.20251<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-12\">Lipton, R.B., et al. (2010). Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura. <em>The Lancet Neurology<\/em>, 9(4), 373-380. <a href=\"https:\/\/doi.org\/10.1177\/0333102413515340\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1177\/0333102413515340<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-13\">Cirillo, P., et al. (2019). Transcranial magnetic stimulation in anxiety and trauma-related disorders: A systematic review and meta-analysis. <em>Brain and Behavior<\/em>, 9(6), e01284. <a href=\"https:\/\/doi.org\/10.1016\/j.jad.2019.01.003\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.jad.2019.01.003<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-14\">Kan, R.L.D., et al. (2020). Non-invasive brain stimulation for posttraumatic stress disorder: A systematic review and meta-analysis. <em>Journal of Psychiatric Research<\/em>, 127, 93-102. <a href=\"https:\/\/doi.org\/10.1016\/j.jpsychires.2020.08.028\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.jpsychires.2020.08.028<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-15\">Lefaucheur, J.P., et al. (2020). Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018). <em>Clinical Neurophysiology<\/em>, 131(2), 474-528. <a href=\"https:\/\/doi.org\/10.1016\/j.jpain.2019.09.014\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.jpain.2019.09.014<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-16\">Diana, M., et al. (2017). Rehabilitating the addicted brain with transcranial magnetic stimulation. <em>Nature Reviews Neuroscience<\/em>, 18(11), 685-693. <a href=\"https:\/\/doi.org\/10.1016\/j.neubiorev.2018.11.010\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.neubiorev.2018.11.010<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-17\">Rossi, S., et al. (2021). Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert guidelines. <em>Clinical Neurophysiology<\/em>, 132(1), 269-306. <a href=\"https:\/\/doi.org\/10.1016\/j.clinph.2020.02.003\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.clinph.2020.02.003<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-18\">Rush, A.J., et al. (2006). Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: A STAR*D report. <em>American Journal of Psychiatry<\/em>, 163(11), 1905-1917. <a href=\"https:\/\/doi.org\/10.1056\/NEJMoa052964\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1056\/NEJMoa052964<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-19\">Dunner, D.L., et al. (2014). A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: Durability of benefit over a 1-year follow-up period. <em>Journal of Clinical Psychiatry<\/em>, 75(12), 1394-1401. <a href=\"https:\/\/doi.org\/10.1016\/j.brs.2018.01.003\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.brs.2018.01.003<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-20\">Kellner, C.H., et al. (2012). ECT vs pharmacotherapy for elderly depressed patients. <em>American Journal of Psychiatry<\/em>, 169(4), 442. <a href=\"https:\/\/doi.org\/10.1016\/j.biopsych.2016.01.015\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.biopsych.2016.01.015<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<li id=\"ref-21\">Philip, N.S., et al. (2016). Maintenance transcranial magnetic stimulation treatment for depression: Durability of effect. <em>Brain Stimulation<\/em>, 9(5), 772-773. <a href=\"https:\/\/doi.org\/10.1016\/j.brs.2018.12.977\" target=\"_blank\" rel=\"noopener nofollow\">https:\/\/doi.org\/10.1016\/j.brs.2018.12.977<\/a>&#8221; target=&#8221;_blank&#8221; rel=&#8221;noopener&#8221;>DOI<\/a><\/li>\n<\/ol>\n<\/ol>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"FAQPage\", \"mainEntity\": [{\"@type\": \"Question\", \"name\": \"Does TMS hurt?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Most patients describe the sensation as uncomfortable but tolerable, especially during the first few sessions. It feels like a tapping or knocking on the scalp. The discomfort typically decreases over the course of treatment as you adapt. Your clinician can adjust the intensity if it is too uncomfortable.\"}}, {\"@type\": \"Question\", \"name\": \"Can TMS make depression worse?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Worsening of symptoms is uncommon but has been reported in a small percentage of patients. If you notice increased depression, anxiety, or agitation during treatment, notify your provider immediately. Adjusting the stimulation parameters or target location can often address this.\"}}, {\"@type\": \"Question\", \"name\": \"Is TMS the same as electroshock therapy?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"No. TMS and ECT are fundamentally different treatments. ECT passes an electrical current through the brain to induce a seizure under general anesthesia. TMS uses magnetic pulses to stimulate specific brain areas without inducing a seizure, without anesthesia, and without memory side effects. The confusion is understandable given that both involve the brain and electricity\/magnetism, but the experience and side effect profiles are very different.\"}}, {\"@type\": \"Question\", \"name\": \"How long do TMS results last?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"On average, TMS benefits last 6 to 12 months or longer. Some patients maintain improvement for years. If symptoms return, a shorter reintroduction course can often restore the response. Many patients find that combining TMS with ongoing therapy and\/or medication helps extend the duration of benefit.\"}}, {\"@type\": \"Question\", \"name\": \"Can I take medication during TMS treatment?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Yes. In fact, most patients continue their current medications during TMS. Your provider will review your medication list to ensure nothing you are taking significantly increases seizure risk. In some cases, medication adjustments may be recommended before starting treatment.\"}}]}<\/script><\/p>\n<div style=\"display:flex;gap:16px;align-items:center;border:1px solid #e2e8f0;background:#f8fafc;border-radius:10px;padding:16px 18px;margin:32px 0 8px;\"><img decoding=\"async\" src=\"https:\/\/regenerated.com\/blog\/wp-content\/uploads\/2026\/07\/dr-bronwyn-holmes.webp\" alt=\"Dr. Bronwyn Holmes, MD, FAARFM\" width=\"64\" height=\"64\" style=\"border-radius:50%;flex:none;object-fit:cover;\" loading=\"lazy\"\/><\/p>\n<div>\n<p style=\"margin:0;font-size:0.78em;letter-spacing:1px;text-transform:uppercase;color:#0f766e;font-weight:600;\">About the medical reviewer<\/p>\n<p style=\"margin:3px 0 0;\"><a href=\"https:\/\/regenerated.com\/blog\/reviewers\/bronwyn-holmes\/\"><strong>Dr. Bronwyn Holmes, MD, FAARFM<\/strong><\/a> is a physician specialising in regenerative medicine, advanced peptide therapeutics, exosome and stem cell biology, hormonal health, and longevity. Last reviewed July 5, 2026.<\/p>\n<\/div>\n<\/div>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"MedicalWebPage\", \"@id\": \"https:\/\/regenerated.com\/blog\/tms-therapy-guide\/#reviewed\", \"url\": \"https:\/\/regenerated.com\/blog\/tms-therapy-guide\/\", \"lastReviewed\": \"2026-07-05\", \"reviewedBy\": {\"@type\": \"Person\", \"name\": \"Dr. Bronwyn Holmes\", \"honorificSuffix\": \"MD, FAARFM\", \"url\": \"https:\/\/regenerated.com\/blog\/reviewers\/bronwyn-holmes\/\", \"@id\": \"https:\/\/regenerated.com\/blog\/reviewers\/bronwyn-holmes\/#person\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A complete guide to transcranial magnetic stimulation (TMS) therapy. Covers how TMS works, types of TMS (rTMS, deep TMS, theta burst), FDA-cleared uses for depression and OCD, what sessions are like, side effects, costs, insurance coverage, and how it compares to medication, ECT, and ketamine.<\/p>\n","protected":false},"author":1,"featured_media":6646,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_regenerated_references":"","footnotes":""},"categories":[1003],"tags":[],"class_list":["post-5957","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-neuromodulation-brain-health"],"_links":{"self":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5957","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/comments?post=5957"}],"version-history":[{"count":6,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5957\/revisions"}],"predecessor-version":[{"id":6948,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5957\/revisions\/6948"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media\/6646"}],"wp:attachment":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media?parent=5957"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/categories?post=5957"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/tags?post=5957"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}